Influence of MSC treatment on blood–brain barrier permeability. The intensity of Evan’s blue determined by spectrofluorometry showed that administration of MSCs reduced BBB leakage when compared with the PBS-treated group 24 and 72 h after ICH. n = 6 in each time point per group. Data are presented as the mean ± SD. *P < 0.05.